Biohaven Ltd. (BHVN)
NYSE: BHVN
· Real-Time Price · USD
16.48
-0.88 (-5.07%)
At close: Oct 16, 2025, 3:59 PM
16.23
-1.49%
After-hours: Oct 16, 2025, 07:58 PM EDT
-5.07% (1D)
| Bid | 16.16 |
| Market Cap | 1.74B |
| Revenue (ttm) | 3.84M |
| Net Income (ttm) | -766.97M |
| EPS (ttm) | -7.46 |
| PE Ratio (ttm) | -2.21 |
| Forward PE | -2.79 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 17 |
| Volume | 1,800,397 |
| Avg. Volume (20D) | 2,266,125 |
| Open | 17.15 |
| Previous Close | 17.36 |
| Day's Range | 16.10 - 17.58 |
| 52-Week Range | 12.79 - 54.98 |
| Beta | 3.45 |
| Ex-Dividend Date | n/a |
About BHVN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BHVN
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BHVN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsBiohaven Ltd. is scheduled to release its earnings on
Nov 11, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
+8.97%
Biohaven shares are trading higher after Citigroup...
Unlock content with
Pro Subscription
1 month ago
+6.34%
Biohaven shares are trading higher after the company announced that the FDA review of Troriluzole has moved forward without an advisory committee.
